Orville W. McLenan, MD, FACS

Freeport Location
294 West Merrick Rd., Ste. 2
Freeport, NY 11520
Tel:  516-378-0123
Fax: 516-378-0148

Castle Connolly Top Doctors
Orville W. McLenan, MD, FACS

Orville W. McLenan, MD, FACS

Freeport Location
294 West Merrick Rd., Ste. 2
Freeport, NY 11520
Tel:  516-378-0123
Fax: 516-378-0148

Castle Connolly Top Doctors

Board-Certified Urologist | General Urology | Minimally Invasive & Reconstructive Urology Specialist

Dr. Orville W. McLenan is a board-certified urologist with extensive experience in general urology, minimally invasive treatments, and reconstructive techniques. He provides comprehensive, patient-centered care with a focus on advanced diagnostics and effective surgical management.

Dr. McLenan has been in private practice in Freeport, New York since 1999, providing comprehensive urologic care across a wide range of conditions. He completed extensive training through New York University School of Medicine and its affiliated hospitals, gaining experience in both general and specialized urologic care.

His clinical interests include the management of urologic cancers, urethral strictures, and minimally invasive treatments, supported by a strong foundation in research and academic contributions.

  • General urology
  • Urologic oncology
  • Urethral stricture disease
  • Erectile dysfunction
  • Minimally invasive urologic procedures
  • Laser therapies in urology

  • Prostate cancer
  • Bladder cancer
  • Kidney and urinary tract cancers
  • Urethral strictures
  • Erectile dysfunction
  • Urinary tract conditions
  • General urologic conditions

  • English 

  • B.Sc., University of the West Indies
  • Undergraduate Studies, Queens College, City University of New York
  • M.D., SUNY Downstate Health Sciences University
  • Surgical Residency, New York University School of Medicine (Bellevue Hospital, Manhattan VA, Tisch Hospital, NYU Downstate)
  • Urology Residency, New York University School of Medicine (including Memorial Sloan Kettering Cancer Center and Cabrini Medical Center)

  • American Board of Urology (Certified February 2001)
  • Fellow, American College of Surgeons (FACS)

  • American Urological Association
  • American Medical Association
  • New York Section, American Urological Association
  • American College of Surgeons

Dr. McLenan has conducted research in urologic oncology and minimally invasive therapies, including work on Uroplakin II as a biomarker for transitional cell carcinoma and the use of holmium laser technology for urethral strictures.

He has presented at the Ferdinand C. Valentine Resident Essay Meeting and has publications in peer-reviewed journals, including the Journal of Urology.

Reviews